{"groups":[{"description":"Patients must have no nausea and/or vomiting for 24 hours and must not have used other anti-emetics for 72 hours prior to starting protocol treatment. Treatment must not start until this criteria is satisfied.\n\n\\- Any germ cell chemotherapy regimen utilizing Cisplatin (20mg/m\\^2 x 5 days).\n\nAcute emesis prophylaxis:\n\n* Any 5HT3 receptor antagonist may be used D1 - 5 or D1, 3 and 5 if palonosetron is used per institutional standards.\n* Dexamethasone 20mg PO (orally) daily, D1 and 2\n* Fosaprepitant 150mg IV on day 3\n\nDelayed emesis prophylaxis:\n\n* Fosaprepitant 150mg IV on D5\n* Dexamethasone 4mg PO BID (twice a day) on D6, 7 and 8\n\nPRN antiemetics allowed at the discretion of the treating investigator\n\n* No additional doses of 5HT3 receptor antagonist, dexamethasone, or fosaprepitant will be given during the acute or delayed treatment periods\n\nFosaprepitant: Fosaprepitant 150mg IV D3 for acute prophylaxis Fosaprepitant 150mg IV on Day 5 for delayed prophyl","id":"FG000","title":"Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"10"}],"type":"Protocol Violation"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"65"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"54"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"11"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}